Wainman Paul R has filed 4 insider transactions across 1 company since December 2022.
Most recent transaction: a grant/award of 11933 shares of IMMUCELL CORP /DE/ ($ICCC) on April 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 15, 2026 | IMMUCELL CORP /DE/ | $ICCC | Wainman Paul R | Director | A | Non Qualified Stock Options (Right to buy) | 11933 | $0.00 | 11,933.0000 | 9,045,851 | 9999.99% | 0.13% |
| April 16, 2025 | IMMUCELL CORP /DE/ | $ICCC | Wainman Paul R | Director | A | Non Qualified Stock Options (Right to buy) | 10000 | $0.00 | 10,000.0000 | 8,979,091 | 9999.99% | 0.11% |
| Sept. 20, 2024 | IMMUCELL CORP /DE/ | $ICCC | Wainman Paul R | Not found | A | Non Qualified Stock Options (Right to buy) | 10000 | $3.60 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2022 | IMMUCELL CORP /DE/ | $ICCC | Wainman Paul R | Director | A | Non Qualified Stock Options (Right to buy) | 10000 | $6.52 | 10,000.0000 | 0 | 9999.99% | 0.00% |